Digital Biomarkers for Depression: French Trial Tests Computer Vision to Assess Severe Depression in Hospitalised Patients
247 Health News Editorial
·13 May 2026
·4 min read
·clinical-trialsFrench researchers are testing computer vision technology to objectively assess depression severity in hospitalised patients. The CALYPSO project combines traditional clinical scales with facial analysis, voice patterns, and physiological monitoring to develop digital biomarkers for severe depression.
Originally reported by ClinicalTrials.gov
References
- 1.University Hospital, Lille. (2024). Evaluation of New Computer Vision Methods to Characterize Depression Severity in Patients Hospitalized for Severe Depression. ClinicalTrials.gov. NCT06095310. https://clinicaltrials.gov/study/NCT06095310
- 2.Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23(1), 56-62. https://doi.org/10.1136/jnnp.23.1.56
- 3.Torous, J., Staples, P., & Onnela, J. P. (2015). Realizing the potential of mobile mental health: new methods for new data in psychiatry. Current Psychiatry Reports, 17(8), 602. https://doi.org/10.1007/s11920-015-0602-0
- 4.Jacobson, N. C., & Chung, Y. J. (2019). Passive sensing of prediction of moment-to-moment depressed mood among undergraduates with clinical levels of depression. Sensors, 19(15), 3572. https://doi.org/10.3390/s19153572
- 5.World Health Organization. (2023). Depressive disorder (depression). WHO Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/depression
- 6.Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service